Brisbane's Mater Hospital is starting trials on a universal flu vaccine that it hopes could do away with the need for yearly jabs.
Researchers at the Mater have launched a clinical trial of vaccine OVX836, which targets the internal nucleoprotein of the flu virus, the part that is less susceptible to mutations.
